Nuclear Medicine Equipment Market
Nuclear Medicine Equipment Market – Analysis, Outlook, Growth Trends, and Forecast
Nuclear Medicine Equipment Market Analysis by Product , Application, End User & Region - Forecast 2022 - 2032
Nuclear Medicine Equipment Market Outlook (2022-2032)
[342 Pages Report] The nuclear medical equipment market is estimated to grow at a stable CAGR of 4.1% between 2022 and 2032. The market for nuclear medical equipment is expected to expand from US$ 2.3 Billion in 2022 to US$ 3.4 Billion in 2032, supported by:
- The increasing frequency of cancer and cardiovascular illness, as well as the growing need for image-guided operations and diagnostics.
- Rising SPECT and PET applications, as well as rising public awareness of healthcare, are likely to boost the market in the next years.
- Nuclear medicine's success may be attributed to the fact that it provides a unique and non-invasive access to information at the molecular and cellular levels that other imaging technologies cannot imitate.
- Increased diagnostic nuclear medicine operations will assist to boost nuclear medicine equipment demand forward in the approaching years.
- Radiopharmaceutical use in diagnostics is expanding at a rate of more than 10% per year worldwide. Reduced funding for medical imaging, a lack of cost-effectiveness statistics and evidence to show that nuclear medicine improves patient outcomes, and a lack of anatomic and molecular imaging training among physicians and radiologists are all likely to slow the growth of the nuclear medicine equipment market.
During the COVID-19 pandemic, there was a decline in traditional nuclear imaging operations in electric surgery for cardiovascular disorders and cancer diagnosis. As a result, demand for a variety of equipment, including SPECT, has fallen. This has had a detrimental impact on the nuclear medical equipment market forecast.
During the pandemic, hospitals and healthcare institutions throughout the world postponed non-elective treatments in order to focus on treating the large number of corona virus patients. As a result, the use of nuclear medical equipment has declined.
|
Data Points |
Key Statistics |
|
Expected Market Value in 2022 |
US$ 2.3 Billion |
|
Projected Market Value in 2032 |
US$ 3.4 Billion |
|
Growth Rate (2016-2026) |
4.1% CAGR |
Let us know your requirement to get
100% FREE customization
Development of Nuclear Medicine Equipment Market in the North America
Nuclear medicine equipment’s primary market is North America. The United States is one of the main radioisotope consumer markets in North America, and Canada is one of the primary manufacturers of Tc-99m.
The robust growth of the healthcare sector in the United States, rising cancer incidences, a growing geriatric population, and an increase in product launches leading to increased use of radioisotopes, as well as increased initiatives and investments in advanced cancer treatment, are expected to drive market growth.
Opportunities abound in the Hospital Segment
The hospital sector will account for the largest nuclear medicine equipment market share during the forecast period 2022-2032, owing to increased healthcare spending by emerging global economies and the presence of highly established and sophisticated healthcare infrastructure in developed nations.
Furthermore, the rise in lifestyle conditions such as cardiovascular disease and cancer has increased the target patient population as well as the need for early identification and treatment by hospitals worldwide.
Because of the rise in lifestyle diseases, governmental and corporate organisations have increased their investment in Research Centers, making this the fastest growing sector with a CAGR of 4.8%. The market for nuclear medical equipment is expanding.
As per nuclear medicine equipment market study, the nuclear medicine's success can be ascribed to the fact that it supplies a unique and non-invasive approach to information at the molecular and cellular level that is unique and cannot be replicated by other imaging technologies.
It also aids in the early detection of sickness and is one of the market's most favourable drivers, as public awareness of chronic diseases grows. Increased diagnostic nuclear medicine procedures around the world will help to propel the demand for nuclear medicine equipment forward in the coming years.
According to supporting data, the usage of radiopharmaceuticals in diagnostics is increasing at a rate of over 10% per year over the world. Reduced funding for medical imaging, a lack of cost-effectiveness statistics and evidence to prove that nuclear medicine improves patient outcomes, and a dearth of anatomic and molecular imaging training among physicians and radiologists are all likely to slow the nuclear medicine equipment market expansion.
The adoption of nuclear medicine equipment has been rising at a rapid rate, which is both stimulating and boosting the market for nuclear medical equipment. Furthermore, the growing awareness of the necessity of early disease diagnosis, as well as the high acceptance of nuclear medicine equipment by end users, leads the nuclear medicine equipment market to have a high adoption rate among the patients.
Increased investment in diagnostic imaging centre renovations, as well as the development of new radiotracers, will additionally fuel demand for nuclear medicine equipment. The constant development of new and upgraded goods is also having a significant impact on the nuclear medicine equipment market size.
Through the emerging trends in the nuclear medicine equipment market, a long-term product pipeline, rising disease incidence among the ageing population, and increased demand for nuclear medical operations are all contributing to the said market growth.
While the prohibitive cost of nuclear medicine equipment and reduced half-life radiopharmaceuticals, as well as a lack of effective data and proof that nuclear medicine improves patient outcomes, are projected to stymie the target market's growth throughout the forecast period. Furthermore, the introduction of new and sophisticated goods is boosting the sales of nuclear medicine equipment.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Is Propelling The Nuclear Medicine Equipment Market?
Nuclear imaging system advancements are expected to boost product demand for nuclear medicine equipment. Nuclear imaging technologies such as PET and SPECT have advanced to the point where they can now be employed in fields other than oncology, cardiology, and neurology.
For example, the introduction of SPECT detectors based on cadmium zinc telluride has aided in the simultaneous viewing of physiological and anatomical systems. During the forecast period, this will drive global demand for nuclear medicine equipment.
What Restrains The Nuclear Medicine Equipment Market?
In developing regions, a lack of research facilities and funding is expected to stifle the nuclear medicine equipment market growth.
Because of a lack of adequate funding in developing countries, even basic nuclear medicine equipment like as phantoms is becoming scarce. It has also slowed the expansion of medical research centres and radiation-protection technology.
Furthermore, the average cost of patient healthcare in poor countries is 1000 times lower than in affluent countries like the United States. As a result, hospitals have little motivation to invest in costly nuclear medicine equipment. This is reducing the market opportunities for sales of nuclear medicine equipment.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What Are The Trends In The Nuclear Medicine Equipment Market?
The market for nuclear medicine equipment is expected to be fuelled by an increase in the prevalence of the target patient population.
Cancer alone claimed the lives of approximately 10 million people globally, according to the World Health Organization (WHO). Both the developed and developing worlds are expected to see a rise in cancer cases.
It is expected that one out of every nine Indians will develop cancer at some point in their lives. Heart disease is the leading cause of death worldwide, accounting for 16 percent of all deaths. Early detection increases the odds of survival dramatically, and nuclear medicine equipment plays a critical part in this. This has led to a rapid rise in the adoption of nuclear medicine equipment.
Comparative View Of Adjacent Nuclear Medicine Equipment Market
Nuclear Medicine Equipment Market:
|
Attributes |
Nuclear Medicine Equipment Market |
|
CAGR (2022-2032) |
4.1% |
|
Market Value (2026) |
US$ 3.4 Billion |
|
Growth Factor |
The market growth is expected to be fuelled by an increase in the prevalence of the target patient population. |
|
Opportunity |
Nuclear imaging system advancements are expected to enhance the market growth. |
|
Key Trends |
The growing awareness of the necessity of early disease diagnosis, as well as the high acceptance of nuclear medicine equipment by end users, leads the demand for nuclear medicine equipment to have a high adoption rate. |
Nuclear Medicine Market:
|
Attributes |
Nuclear Medicine Market |
|
CAGR (2022-2032) |
9% |
|
Market Value (2026) |
US$ 7.5 Billion |
|
Growth Factor |
Increasing the incidence and prevalence of cancer and heart disease, as well as measures to close the Mo-99 demand-supply imbalance is driving the market. |
|
Opportunity |
Neurological implications of radiopharmaceuticals are opening new horizons in the market. |
|
Key Trends |
Radiopharmaceuticals' short half-life limits their potential adoption, while hospital budget cuts and costly equipment expenses are projected to impede market growth. |
Radiation Detection, Monitoring, & Safety Market:
|
Attributes |
Radiation Detection, Monitoring, & Safety Market |
|
CAGR (2022-2032) |
6.9% |
|
Market Value (2026) |
US$ 3.1 Billion |
|
Growth Factor |
Increasing security dangers, global cancer prevalence, and increased radiation safety awareness are leading the market. |
|
Opportunity |
Increased use of nuclear medicine and radiation therapy for diagnosis and treatment, as well as an increase in the number of PET/CT scans. |
|
Key Trends |
The market for homeland security applications will be fuelled by rising military spending. |
Geographically, North America was expected to have the highest nuclear medicine equipment market share in 2020, and it is expected to continue to dominate the market over the forecast period of 2021-2026, owing to the region's highly developed healthcare system and growing target patient population.
Globally, lifestyle disorders like as cancer and cardiovascular ailments are expected to boost the market trends, but the Covid-19 epidemic led to slow down in the growth of demand for nuclear medicine equipment, as patients are afraid of infection, resulting in fewer hospital visits.
Which Is The Leading Segment In The Nuclear Medicine Equipment Market By End User?
During the projection period 2021-2026, the hospital sector will account for the biggest nuclear medicine equipment market share, owing to rising healthcare spending by emerging global economies and the presence of highly established and advanced healthcare infrastructure in developed countries.
Furthermore, the rise in lifestyle disorders such as cardiovascular disease and cancer has led in an increase in the target patient population and a demand for early detection and treatment by hospitals around the world.
As a result of the increase in lifestyle illnesses, governmental and private entities have boosted their investment in Research Centers, making this area the fastest expanding with a CAGR of 4.8 percent. The nuclear medicine equipment market opportunities are on the rise.
Which Is The Leading Segment In The Nuclear Medicine Equipment Market By Product Type?
The SPECT segment was forecasted to dominate the said market in 2020, and it is expected to continue to do so with a CAGR of 4.7 percent over the forecast period. This is because it is used in a wide range of applications and is also quite inexpensive. Another aspect driving the segment's rise is the surge in technical advancement.
In the category, innovation has resulted in the creation of digital SPECT, which supplies more image detail and sensitivity. Because of its ability to generate 3D images and correct full-body scans, the Hybrid PET segment is expected to increase at the fastest rate during the forecast period. SPECT segment leads the nuclear medicine equipment market with the projected CAGR of 4.92% by 2032.
Regional Insights
Which is the Leading Region in the Nuclear Medicine Equipment Market?
North America is a significant regional segment due to the rapid rise of nuclear medicine in the United States because of technical advancements. Furthermore, North America's supremacy is due to the quick release of new radiopharmaceuticals for diagnostics and therapies.
During the projected period, Asia Pacific, on the other hand, is expected to increase at the fastest rate. In the Asia Pacific, Japan has the largest consumer nuclear medicine equipment market.
The practise of nuclear medicine in Japan has advanced significantly in recent years, with a significant increase in the frequency of hybrid SPECT/CT exams. Furthermore, rising demand for Alzheimer's and Parkinson's disease treatment and diagnostics in China and India is fuelling the Asia Pacific sales of nuclear medicine equipment.
|
Regions |
CAGR (2022-2032) |
|
United States |
3.7% |
|
United Kingdom |
3.3% |
|
China |
3.6% |
|
Japan |
2.7% |
|
South Korea |
2.4% |
How Market Competition is Influencing the Nuclear Medicine Equipment Regional Presence?
To increase their market share, key players in the worldwide are focusing on new product launches. Product launches, product approvals, and other organic growth tactics such as patents and events are being prioritised by several companies.
Acquisitions, as well as partnerships and collaborations, were seen as inorganic growth tactics in the target market. These initiatives have paved the road for market players to expand their business and client base and change the nuclear medicine equipment market outlook.
Some of the recent developments in the Nuclear Medicine Equipment market are:
- Curium bought the Austrian radiopharmaceutical business IASON in June 2021 to boost its diagnostic product line's European footprint.
- PYLARIFY injectable was approved by the Food and Drug Administration (FDA) in May 2021 by Lantheus, a US diagnostic imaging agents and equipment firm. The injection is the first PSMA PET imaging agent for prostate cancer that is commercially accessible.
Key players
- Philips Healthcare
- GE Healthcare
- Siemens Healthineers AG
- Digirad Corporation
- Mediso Medical Imaging Systems Ltd
- DDD-Diagnostics A/S
- Neusoft Medical Systems Co. Ltd.
- SurgicEye GmbH
- CMR Naviscan Corporation
Key Segments
By Product:
- SPECT
- Hybrid SPECT
- Standalone SPECT
- Hybrid PET
- Planar Scintigraphy
By Application:
- Oncology
- Cardiology
- Neurology
- Others
By End User:
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Others
By Region:
- North America
- Europe
- Asia Pacific
- MEA
- Latin America
Frequently Asked Questions
The Nuclear Medicine Equipment market is projected to have a CAGR of 4.1% in 2032.
North America is the leading region, with an anticipated CAGR of 3.7% by 2032.
Oncology leads the Nuclear Medicine Equipment market with the projected CAGR of 4.3% by 2032.
The Nuclear Medicine Equipment market is predicted to grow US$ 3.4 Billion by 2032.
SPECT segment leads the market with the projected CAGR of 4.92% by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
8.3.1. SPECT
8.3.1.1. Hybrid SPECT
8.3.1.2. Standalone SPECT
8.3.2. Hybrid PET
8.3.3. Planar Scintigraphy
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
9.3.1. Oncology
9.3.2. Cardiology
9.3.3. Neurology
9.3.4. Others (Orthopedics, Urology, Thyroid Related Disorders, and Gastroenterology)
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
10.3.1. Hospitals
10.3.2. Imaging Centers
10.3.3. Academic & Research Institutes
10.3.4. Others (Pharma/Biotech companies, and CROs)
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product
12.4.3. By End User
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By End User
12.5.4. By Application
13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product
13.4.3. By End User
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End User
13.5.4. By Application
14. Europe Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product
14.4.3. By End User
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End User
14.5.4. By Application
15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product
15.4.3. By End User
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End User
15.5.4. By Application
16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product
16.4.3. By End User
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End User
16.5.4. By Application
17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.2.2.1. By Product
17.2.2.2. By End User
17.2.2.3. By Application
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.3.2.1. By Product
17.3.2.2. By End User
17.3.2.3. By Application
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.4.2.1. By Product
17.4.2.2. By End User
17.4.2.3. By Application
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.5.2.1. By Product
17.5.2.2. By End User
17.5.2.3. By Application
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.6.2.1. By Product
17.6.2.2. By End User
17.6.2.3. By Application
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.7.2.1. By Product
17.7.2.2. By End User
17.7.2.3. By Application
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.8.2.1. By Product
17.8.2.2. By End User
17.8.2.3. By Application
17.9. BENELUX Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.9.2.1. By Product
17.9.2.2. By End User
17.9.2.3. By Application
17.10. UK Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.10.2.1. By Product
17.10.2.2. By End User
17.10.2.3. By Application
17.11. Nordic Countries Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.11.2.1. By Product
17.11.2.2. By End User
17.11.2.3. By Application
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.12.2.1. By Product
17.12.2.2. By End User
17.12.2.3. By Application
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.13.2.1. By Product
17.13.2.2. By End User
17.13.2.3. By Application
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.14.2.1. By Product
17.14.2.2. By End User
17.14.2.3. By Application
17.15. GCC Countries Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.15.2.1. By Product
17.15.2.2. By End User
17.15.2.3. By Application
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.16.2.1. By Product
17.16.2.2. By End User
17.16.2.3. By Application
17.17. Turkey Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032
17.17.2.1. By Product
17.17.2.2. By End User
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Philips Healthcare
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. GE Healthcare
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Siemens Healthineers AG
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Digirad Corporation
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Mediso Medical Imaging Systems, Ltd.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. DDD-Diagnostics A/S
19.3.7. Neusoft Medical Systems Co. Ltd.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. SurgicEye GmbH
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. CMR Naviscan Corporation
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn), By Product, 2015 – 2032
Table 2: Global Market Value (US$ Mn), By Product, 2022 – 2032
Table 3: Global Market Value (US$ Mn), By End User, 2015 – 2032
Table 4: Global Market Value (US$ Mn), By End User, 2022 – 2032
Table 5: Global Market Value (US$ Mn), By Application, 2015 – 2032
Table 6: Global Market Value (US$ Mn), By Application, 2022 – 2032
Table 7: Global Market, By Region, 2015 – 2032
Table 8: Global Market, By Region, 2022 – 2032
Table 9: North America Market Value (US$ Mn), By Product, 2015 – 2032
Table 10: North America Market Value (US$ Mn), By Product, 2022 – 2032
Table 11: North America Market Value (US$ Mn), By End User, 2015 – 2032
Table 12: North America Market Value (US$ Mn), By End User, 2022 – 2032
Table 13: North America Market Value (US$ Mn), By Application, 2015 – 2032
Table 14: North America Market Value (US$ Mn), By Application, 2022 – 2032
Table 15: North America Market, By Country, 2015 – 2032
Table 16: North America Market, By Country, 2022 – 2032
Table 17: Latin America Market Value (US$ Mn), By Product, 2015 – 2032
Table 18: Latin America Market Value (US$ Mn), By Product, 2022 – 2032
Table 19: Latin America Market Value (US$ Mn), By End User, 2015 – 2032
Table 20: Latin America Market Value (US$ Mn), By End User, 2022 – 2032
Table 21: Latin America Market Value (US$ Mn), By Application, 2015 – 2032
Table 22: Latin America Market Value (US$ Mn), By Application, 2022 – 2032
Table 23: Latin America Market, By Country, 2015 – 2032
Table 24: Latin America Market, By Country, 2022 – 2032
Table 25: Europe Market Value (US$ Mn), By Product, 2015 – 2032
Table 26: Europe Market Value (US$ Mn), By Product, 2022 – 2032
Table 27: Europe Market Value (US$ Mn), By End User, 2015 – 2032
Table 28: Europe Market Value (US$ Mn), By End User, 2022 – 2032
Table 29: Europe Market Value (US$ Mn), By Application, 2015 – 2032
Table 30: Europe Market Value (US$ Mn), By Application, 2022 – 2032
Table 31: Europe Market, By Country, 2015 – 2032
Table 32: Europe Market, By Country, 2022 – 2032
Table 33: Asia Pacific Market Value (US$ Mn), By Product, 2015 – 2032
Table 34: Asia Pacific Market Value (US$ Mn), By Product, 2022 – 2032
Table 35: Asia Pacific Market Value (US$ Mn), By End User, 2015 – 2032
Table 36: Asia Pacific Market Value (US$ Mn), By End User, 2022 – 2032
Table 37: Asia Pacific Market Value (US$ Mn), By Application, 2015 – 2032
Table 38: Asia Pacific Market Value (US$ Mn), By Application, 2022 – 2032
Table 39: Asia Pacific Market, By Country, 2015 – 2032
Table 40: Asia Pacific Market, By Country, 2022 – 2032
Table 41: MEA Market Value (US$ Mn), By Product, 2015 – 2032
Table 42: MEA Market Value (US$ Mn), By Product, 2022 – 2032
Table 43: MEA Market Value (US$ Mn), By End User, 2015 – 2032
Table 44: MEA Market Value (US$ Mn), By End User, 2022 – 2032
Table 45: MEA Market Value (US$ Mn), By Application, 2015 – 2032
Table 46: MEA Market Value (US$ Mn), By Application, 2022 – 2032
Table 47: MEA Market, By Country, 2015 – 2032
Table 48: MEA Market, By Country, 2022 – 2032
Table 49: Global Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 50: Global Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 51: Global Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 52: Global Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 53: North America Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 54: North America Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 55: North America Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 56: North America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 57: Latin America Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 58: Latin America Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 59: Latin America Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 61: Europe Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 62: Europe Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 63: Europe Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 65: Asia Pacific Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 66: Asia Pacific Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 67: Asia Pacific Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 69: MEA Market Incremental $ Opportunity, By Product, 2022 – 2032
Table 70: MEA Market Incremental $ Opportunity, By End User, 2022 – 2032
Table 71: MEA Market Incremental $ Opportunity, By Application, 2022 – 2032
Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share, By Product, 2021 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 5: Global Market Attractiveness Index, By Product – 2022-2032
Figure 6: Global Market Share, By End User, 2021 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 8: Global Market Attractiveness Index, By End User – 2022-2032
Figure 9: Global Market Share, By Application, 2021 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 11: Global Market Attractiveness Index, By Application – 2022-2032
Figure 12: Global Market Share, By Region, 2021 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 14: Global Market Attractiveness Index, By Region – 2022-2032
Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 16: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 17: North America Market Share, By Product, 2021 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 19: North America Market Attractiveness Index, By Product – 2022-2032
Figure 20: North America Market Share, By End User, 2021 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 22: North America Market Attractiveness Index, By End User – 2022-2032
Figure 23: North America Market Share, By Application, 2021 & 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 25: North America Market Attractiveness Index, By Application – 2022-2032
Figure 26: North America Market Share, By Country, 2021 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 28: North America Market Attractiveness Index, By Country – 2022-2032
Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 31: Latin America Market Share, By Product, 2021 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 33: Latin America Market Attractiveness Index, By Product – 2022-2032
Figure 34: Latin America Market Share, By End User, 2021 & 2032
Figure 35: Latin America Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 36: Latin America Market Attractiveness Index, By End User – 2022-2032
Figure 37: Latin America Market Share, By Application, 2021 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 39: Latin America Market Attractiveness Index, By Application – 2022-2032
Figure 40: Latin America Market Share, By Country, 2021 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 42: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 44: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 45: Europe Market Share, By Product, 2021 & 2032
Figure 46: Europe Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 47: Europe Market Attractiveness Index, By Product – 2022-2032
Figure 48: Europe Market Share, By End User, 2021 & 2032
Figure 49: Europe Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 50: Europe Market Attractiveness Index, By End User – 2022-2032
Figure 51: Europe Market Share, By Application, 2021 & 2032
Figure 52: Europe Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 53: Europe Market Attractiveness Index, By Application – 2022-2032
Figure 54: Europe Market Share, By Country, 2021 & 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 56: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 58: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 59: MEA Market Share, By Product, 2021 & 2032
Figure 60: MEA Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 61: MEA Market Attractiveness Index, By Product – 2022-2032
Figure 62: MEA Market Share, By End User, 2021 & 2032
Figure 63: MEA Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 64: MEA Market Attractiveness Index, By End User – 2022-2032
Figure 65: MEA Market Share, By Application, 2021 & 2032
Figure 66: MEA Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 67: MEA Market Attractiveness Index, By Application – 2022-2032
Figure 68: MEA Market Share, By Country, 2021 & 2032
Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 70: MEA Market Attractiveness Index, By Country – 2022-2032
Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032
Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 73: Asia Pacific Market Share, By Product, 2021 & 2032
Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 75: Asia Pacific Market Attractiveness Index, By Product – 2022-2032
Figure 76: Asia Pacific Market Share, By End User, 2021 & 2032
Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 78: Asia Pacific Market Attractiveness Index, By End User – 2022-2032
Figure 79: Asia Pacific Market Share, By Application, 2021 & 2032
Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 81: Asia Pacific Market Attractiveness Index, By Application – 2022-2032
Figure 82: Asia Pacific Market Share, By Country, 2021 & 2032
Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Figure 85: US Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: US Market Share, By Product, 2021 & 2032
Figure 87: US Market Share, By End User, 2021 & 2032
Figure 88: US Market Share, By Application, 2021 & 2032
Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 90: Canada Market Share, By Product, 2021 & 2032
Figure 91: Canada Market Share, By End User, 2021 & 2032
Figure 92: Canada Market Share, By Application, 2021 & 2032
Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 94: Brazil Market Share, By Product, 2021 & 2032
Figure 95: Brazil Market Share, By End User, 2021 & 2032
Figure 96: Brazil Market Share, By Application, 2021 & 2032
Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: Mexico Market Share, By Product, 2021 & 2032
Figure 99: Mexico Market Share, By End User, 2021 & 2032
Figure 100: Mexico Market Share, By Application, 2021 & 2032
Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 102: Germany Market Share, By Product, 2021 & 2032
Figure 103: Germany Market Share, By End User, 2021 & 2032
Figure 104: Germany Market Share, By Application, 2021 & 2032
Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 106: U.K. Market Share, By Product, 2021 & 2032
Figure 107: U.K. Market Share, By End User, 2021 & 2032
Figure 108: U.K. Market Share, By Application, 2021 & 2032
Figure 109: France Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: France Market Share, By Product, 2021 & 2032
Figure 111: France Market Share, By End User, 2021 & 2032
Figure 112: France Market Share, By Application, 2021 & 2032
Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 114: Italy Market Share, By Product, 2021 & 2032
Figure 115: Italy Market Share, By End User, 2021 & 2032
Figure 116: Italy Market Share, By Application, 2021 & 2032
Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 118: BENELUX Market Share, By Product, 2021 & 2032
Figure 119: BENELUX Market Share, By End User, 2021 & 2032
Figure 120: BENELUX Market Share, By Application, 2021 & 2032
Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 122: Nordic Countries Market Share, By Product, 2021 & 2032
Figure 123: Nordic Countries Market Share, By End User, 2021 & 2032
Figure 124: Nordic Countries Market Share, By Application, 2021 & 2032
Figure 125: China Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 126: China Market Share, By Product, 2021 & 2032
Figure 127: China Market Share, By End User, 2021 & 2032
Figure 128: China Market Share, By Application, 2021 & 2032
Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 130: Japan Market Share, By Product, 2021 & 2032
Figure 131: Japan Market Share, By End User, 2021 & 2032
Figure 132: Japan Market Share, By Application, 2021 & 2032
Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 134: South Korea Market Share, By Product, 2021 & 2032
Figure 135: South Korea Market Share, By End User, 2021 & 2032
Figure 136: South Korea Market Share, By Application, 2021 & 2032
Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 138: GCC Countries Market Share, By Product, 2021 & 2032
Figure 139: GCC Countries Market Share, By End User, 2021 & 2032
Figure 140: GCC Countries Market Share, By Application, 2021 & 2032
Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 142: South Africa Market Share, By Product, 2021 & 2032
Figure 143: South Africa Market Share, By End User, 2021 & 2032
Figure 144: South Africa Market Share, By Application, 2021 & 2032
Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 146: Turkey Market Share, By Product, 2021 & 2032
Figure 147: Turkey Market Share, By End User, 2021 & 2032
Figure 148: Turkey Market Share, By Application, 2021 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
